TY - JOUR
T1 - Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe
T2 - A propensity-score matched analysis of cross-sectional studies
AU - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
AU - Uuskula, A.
AU - Rannap, J.
AU - Arendt, V.
AU - Barrio, G
AU - Barros, H
AU - Brummer-Korvenkontio, H
AU - Casabona, J
AU - Croes, E
AU - Des Jarlais, D
AU - Seguin-Devaux, C
AU - Dudas, M
AU - Eritsyan, K
AU - Folch, C
AU - Hatzakis, A
AU - Heimer, R
AU - Heinsbroek, E
AU - Hope, V
AU - Jipa, R
AU - Kivite-Urtane, A.
AU - Levina, O
AU - Lyubimova, A
AU - Malczewski, A
AU - Matser, A
AU - McAuley, A
AU - Meireles, P
AU - Mravcik, V
AU - Op de Coul, E.
AU - Ojavee, SE
AU - Pares-Badell, O
AU - Prins, M
AU - Pulido, J
AU - Romanyak, E
AU - Rosinska, M
AU - Stone, J
AU - Sypsa, V
AU - Talu, A
AU - Tarjan, A
AU - Taylor, A
AU - Vickerman, P
AU - Vorobjov, S.
AU - Dolan, K
A2 - Weijler, L.
A2 - Abagiu, A.
A2 - Seyler, T.
A2 - Wiessing, L.
N1 - Publisher Copyright:
© 2023 Society for the Study of Addiction.
PY - 2023/11
Y1 - 2023/11
N2 - Aims: We measured the association between a history of incarceration and HIV positivity among people who inject drugs (PWID) across Europe. Design, Setting and Participants: This was a cross-sectional, multi-site, multi-year propensity-score matched analysis conducted in Europe. Participants comprised community-recruited PWID who reported a recent injection (within the last 12 months). Measurements: Data on incarceration history, demographics, substance use, sexual behavior and harm reduction service use originated from cross-sectional studies among PWID in Europe. Our primary outcome was HIV status. Generalized linear mixed models and propensity-score matching were used to compare HIV status between ever- and never-incarcerated PWID. Findings: Among 43 807 PWID from 82 studies surveyed (in 22 sites and 13 countries), 58.7% reported having ever been in prison and 7.16% (n = 3099) tested HIV-positive. Incarceration was associated with 30% higher odds of HIV infection [adjusted odds ratio (aOR) = 1.32, 95% confidence interval (CI) = 1.09–1.59]; the association between a history of incarceration and HIV infection was strongest among PWID, with the lowest estimated propensity-score for having a history of incarceration (aOR = 1.78, 95% CI = 1.47–2.16). Additionally, mainly injecting cocaine and/or opioids (aOR = 2.16, 95% CI = 1.33–3.53), increased duration of injecting drugs (per 8 years aOR = 1.31, 95% CI = 1.16–1.48), ever sharing needles/syringes (aOR = 1.91, 95% CI = 1.59–2.28) and increased income inequality among the general population (measured by the Gini index, aOR = 1.34, 95% CI = 1.18–1.51) were associated with a higher odds of HIV infection. Older age (per 8 years aOR = 0.84, 95% CI = 0.76–0.94), male sex (aOR = 0.77, 95% CI = 0.65–0.91) and reporting pharmacies as the main source of clean syringes (aOR = 0.72, 95% CI = 0.59–0.88) were associated with lower odds of HIV positivity. Conclusions: A history of incarceration appears to be independently associated with HIV infection among people who inject drugs (PWID) in Europe, with a stronger effect among PWID with lower probability of incarceration.
AB - Aims: We measured the association between a history of incarceration and HIV positivity among people who inject drugs (PWID) across Europe. Design, Setting and Participants: This was a cross-sectional, multi-site, multi-year propensity-score matched analysis conducted in Europe. Participants comprised community-recruited PWID who reported a recent injection (within the last 12 months). Measurements: Data on incarceration history, demographics, substance use, sexual behavior and harm reduction service use originated from cross-sectional studies among PWID in Europe. Our primary outcome was HIV status. Generalized linear mixed models and propensity-score matching were used to compare HIV status between ever- and never-incarcerated PWID. Findings: Among 43 807 PWID from 82 studies surveyed (in 22 sites and 13 countries), 58.7% reported having ever been in prison and 7.16% (n = 3099) tested HIV-positive. Incarceration was associated with 30% higher odds of HIV infection [adjusted odds ratio (aOR) = 1.32, 95% confidence interval (CI) = 1.09–1.59]; the association between a history of incarceration and HIV infection was strongest among PWID, with the lowest estimated propensity-score for having a history of incarceration (aOR = 1.78, 95% CI = 1.47–2.16). Additionally, mainly injecting cocaine and/or opioids (aOR = 2.16, 95% CI = 1.33–3.53), increased duration of injecting drugs (per 8 years aOR = 1.31, 95% CI = 1.16–1.48), ever sharing needles/syringes (aOR = 1.91, 95% CI = 1.59–2.28) and increased income inequality among the general population (measured by the Gini index, aOR = 1.34, 95% CI = 1.18–1.51) were associated with a higher odds of HIV infection. Older age (per 8 years aOR = 0.84, 95% CI = 0.76–0.94), male sex (aOR = 0.77, 95% CI = 0.65–0.91) and reporting pharmacies as the main source of clean syringes (aOR = 0.72, 95% CI = 0.59–0.88) were associated with lower odds of HIV positivity. Conclusions: A history of incarceration appears to be independently associated with HIV infection among people who inject drugs (PWID) in Europe, with a stronger effect among PWID with lower probability of incarceration.
KW - Europe
KW - HIV
KW - PWID
KW - Incarceration
KW - Injection drug use
KW - Prison
KW - incarceration
KW - prison
KW - injection drug use
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:001042130200001&DestLinkType=FullRecord&DestApp=WOS
UR - https://www.mendeley.com/catalogue/cd68018b-f553-3a58-960f-6fdb5da70826/
UR - http://www.scopus.com/inward/record.url?scp=85173932021&partnerID=8YFLogxK
U2 - 10.1111/add.16283
DO - 10.1111/add.16283
M3 - Article
SN - 0965-2140
VL - 118
SP - 2177
EP - 2192
JO - Addiction
JF - Addiction
IS - 11
ER -